FDA Inspection
Jazz Pharmaceuticals, IncJazz Pharmaceuticals, Inc – FDA Inspection, May 6, 2011
Record Details
This FDA Inspection record concerns Jazz Pharmaceuticals, Inc, with an inspection on May 6, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Jazz Pharmaceuticals, Inc
- Inspection Date
- May 6, 2011
- Product Type
- Drugs
View Company Profile
ID · 94972bdf-d011-4e2b-8c6a-3f1eff3e6356
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 721416
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 314.80(c)(2)Failure to report non-alert ADEs
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Jazz Pharmaceuticals, Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2019 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 10, 2017 | Not classified | San Francisco District Office | |
| July 20, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 4, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Jazz Pharmaceuticals, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.